...
机译:单核苷酸多态性阵列为移植后弥漫性大B细胞淋巴瘤的发病机理提供新的见解
Laboratory of Experimental Oncology and Lymphoma Unit, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland;
Division of Haematology, Department of Clinical and Experimental Medicine & BRMA, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;
Laboratory of Experimental Oncology and Lymphoma Unit, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland;
Department of Pathology and Microbiology, University of Nebraska, Omaha, NE;
Department of Pathology and Microbiology, University of Nebraska, Omaha, NE;
Institute for Cancer Genetics and Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA;
Division of Haematology, Department of Clinical and Experimental Medicine & BRMA, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;
Divisions of Pathology and Haematology, Ospedale Niguarda Ca’ Granda, Milan;
Department of Pathology, IRCCS Policlinico San Matteo/University of Pavia, Pavia;
Division of Haematology, Ospedali Riuniti, Bergamo, Italy;
Laboratory of Experimental Oncology and Lymphoma Unit, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland|Istituto Dalle Molle di Studi sull’Intelligenza Artificiale (IDSIA), Manno, Switzerland;
Department of Biomedical Science and Human Oncology, Center of Experimental Medicine and Research (CeRMS), University of Turin, Turin;
Pathology Unit & Unit of Lymphoid Malignancies, San Raffaele H Scientific Institute Milan, Italy;
Programa de Patologia Molecular, Centro Nacional de Investigaciones Oncologicas (CNIO), Madrid, Spain;
Programa de Patologia Molecular, Centro Nacional de Investigaciones Oncologicas (CNIO), Madrid, Spain;
Laboratory of Experimental Oncology and Lymphoma Unit, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland;
Laboratory of Experimental Oncology and Lymphoma Unit, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland;
Laboratory of Experimental Oncology and Lymphoma Unit, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland;
Institute for Cancer Genetics and Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA;
Division of Haematology, Department of Clinical and Experimental Medicine & BRMA, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;
Laboratory of Experimental Oncology and Lymphoma Unit, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland|Istituto Dalle Molle di Studi sull’Intelligenza Artificiale (IDSIA), Manno, Switzerland;
Laboratory of Experimental Oncology and Lymphoma Unit, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland;
Affymetrix; comparative genomic hybridization; diffuse large B-cell lymphoma; human immunodeficiency virus; immunodeficiency; solid organ transplant;
机译:单核苷酸多态性阵列为移植后弥漫性大B细胞淋巴瘤的发病机理提供了新的见解。
机译:单药brentuximab vedotin治疗的移植后淋巴增生性疾病和终末期肾脏疾病患者的CD30阳性弥漫性大B细胞淋巴瘤完全缓解
机译:弥漫性大B细胞淋巴瘤分子亚型发病机制的新颖见解及其临床意义
机译:HIP1R在B细胞亚群中的表达特征及其在弥漫性大B细胞淋巴瘤中的功能的计算机预测
机译:BLIMP1和A20失活在弥漫性大B细胞淋巴瘤发病机理中的作用。
机译:活化的B细胞样弥漫性大B细胞淋巴瘤的分子发病机理的见解及其治疗意义。
机译:Interleukin-10 promoter single nucleotide polymorphism in non-Hodgkin's lymphoma and diffuse large B-cell lymphoma.